UroGen Pharma Ltd. (URGN)
27.65
-4.08
(-12.86%)
USD |
NASDAQ |
Nov 20, 16:00
27.69
+0.04
(+0.14%)
After-Hours: 20:00
UroGen Pharma Debt to Equity Ratio : -1.568 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | -1.568 |
| June 30, 2026 | -1.481 |
| March 31, 2026 | -1.586 |
| December 31, 2025 | -1.233 |
| September 30, 2025 | -1.126 |
| June 30, 2025 | -1.365 |
| March 31, 2025 | -2.720 |
| December 31, 2024 | -14.19 |
| September 30, 2024 | 4.811 |
| June 30, 2024 | 3.267 |
| March 31, 2024 | -2.467 |
| December 31, 2023 | -1.537 |
| September 30, 2023 | -2.391 |
| June 30, 2023 | -0.7254 |
| March 31, 2023 | -0.8606 |
| December 31, 2022 | -1.120 |
| September 30, 2022 | -1.180 |
| June 30, 2022 | -1.797 |
| March 31, 2022 | -4.217 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.4431 |
| September 30, 2021 | 0.0555 |
| June 30, 2021 | 0.0357 |
| March 31, 2021 | 0.0384 |
| December 31, 2020 | 0.0348 |
| September 30, 2020 | 0.0256 |
| June 30, 2020 | 0.0243 |
| March 31, 2020 | 0.0259 |
| December 31, 2019 | 0.0144 |
| September 30, 2019 | 0.0083 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Xencor, Inc. | 0.2859 |
| MeiraGTx Holdings Plc | 0.6223 |
| Ironwood Pharmaceuticals, Inc. | -3.459 |
| Viking Therapeutics, Inc. | 0.4327 |
| IDEAYA Biosciences, Inc. | 0.0272 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 271.87M |
| Total Liabilities (Quarterly) | 397.09M |
| Shareholders Equity (Quarterly) | -125.22M |
| Current Ratio | 3.403 |
| Net Debt Paydown Yield | -0.69% |